XPH Looks Tempting, but the Five-Year Chart Warns Investors
SPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
Benchmarks provide objective yardsticks to assess results, set expectations, and keep portfolios aligned with objectives.
20,321 articlesSPDR S&P Pharmaceuticals ETF has delivered a standout one-year run, yet the longer five-year view casts a shadow. The...
The memory market is famous for wild swings. This guide breaks down what Micron does, where demand may come from, and...
Think it's late invest? You're not out of luck. Even if retirement feels distant, small, steady actions can compound ...
A renowned remote-work strategist warns that the 2026 labor market remains tight and cautious. Workers tied to curren...
Red Cat stock crashed today after the company announced a large share offering to raise capital. This piece breaks do...
As the Dow marks its 130th birthday, savvy investors look for steady income and durable growth. Here are three blue c...
ASML Holding stock popped today as investors weighed AI-driven demand, backlog strength, and a brighter outlook for c...
Two former governors unveil a bipartisan coalition designed to prepare America’s workforce for an AI-driven future, w...
As an investor, timing updates can boost or trim returns. This guide breaks down whether should taiwan semiconductor ...
In a bold move amid 13F season, investor Gavin Baker places a major levered bet on Nvidia through call options, signa...
AI data centers are expanding fast, backed by major cloud players. This article dives into why hyperscalers plan spen...
Salesforce surged Thursday as the company announced a major debt offering to back a sizable share repurchase plan. Th...